Skip to main content

Sara Van Driest Archives

For more precise drug treatments, ‘squeeze’ the genome: study finds

Jul. 22, 2021—Large-scale studies will be required to identify the complexity of genetic variations that affect how patients respond to a given drug and whether they will have side effects, according to researchers at Vanderbilt University Medical Center.

Read more


Gene variant linked to unnecessary bone marrow biopsies in African Americans

Jun. 28, 2021—A gene variant that lowers white blood cell levels and is common in individuals with African ancestry contributes to unnecessary bone marrow biopsies, according to a study published June 28 in JAMA Internal Medicine.

Read more


PREDICT program expands, opens new Genomics Clinic

Apr. 30, 2020—A new clinic opening at Vanderbilt University Medical Center will help doctors and patients choose the best drugs for their medical conditions based on the patients’ unique genetic makeup.

Read more


Study finds acid reducers may pose risk for children

Nov. 6, 2019—The use of acid reducers among children is on the rise and so are potential side effects, which is sparking concern according to a recent study.

Read more


Study: personalized decision support affects intensive care

Oct. 3, 2019—For patients in pediatric intensive care who are at high risk for acute kidney injury (AKI), giving clinicians automated decision support during the electronic order entry process increased the rate of blood testing for AKI by 9%.

Read more


Van Driest lands young investigator award from the American Society for Clinical Pharmacology and Therapeutics

May. 22, 2019—Sara Van Driest, MD, PhD, assistant professor of Pediatrics and Medicine, recently received the 2019 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics.

Read more


PheWAS Core helps researchers make sense of electronic health record data

Feb. 7, 2019—Some biomedical researchers may be unsure about routine electronic health record (EHR) data and how useful it ultimately may prove for drawing meaningful, actionable associations that warrant changes to clinical practice and lead to improved clinical outcomes.

Read more


Study finds acetaminophen helps reduce acute kidney injury risk in children following cardiac surgery

May. 24, 2018—Children who underwent cardiac surgery were less likely to develop acute kidney injury if they had been treated with acetaminophen in the first 48 hours after their procedures, according to a Vanderbilt study just published in JAMA Pediatrics.

Read more


Personalized drug prescribing program expands, upgrades

Jan. 25, 2018—Vanderbilt University Medical Center (VUMC) has expanded and relaunched genetic testing to predict patient responses to drugs.

Read more


Doris Duke Foundation lauds Van Driest’s research

Jul. 27, 2017—Sara Van Driest, M.D., Ph.D., who is developing methods for precision dosing of pediatric medications at Vanderbilt University Medical Center (VUMC), has received a 2017 Clinical Scientist Development Award from the Doris Duke Charitable Foundation.

Read more


New screening model quickly spots acute kidney injury

Jun. 8, 2017—Researchers at Vanderbilt University Medical Center (VUMC) have developed a screening tool intended to more quickly identify patients with acute kidney injury (AKI).

Read more


Vanderbilt study raises questions about reporting incidental genetic findings

Jan. 5, 2016—A genetic test that suggests a patient may be at increased risk for potentially fatal heart rhythms is very often not as ominous as it sounds.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more